133 related articles for article (PubMed ID: 31157483)
1. The importance of pH reflux monitoring test for the management of low-grade esophagitis in Chinese patients.
Qiu B; Zhang X; Bai T; Xu J; Xiang X; Hou X
Neurogastroenterol Motil; 2019 Sep; 31(9):e13653. PubMed ID: 31157483
[TBL] [Abstract][Full Text] [Related]
2. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
Zhang M; Tan N; Li Y; Chen M; Xiao Y
Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
[TBL] [Abstract][Full Text] [Related]
3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
5. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
6. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
Jain M; Agrawal V
Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
Mahoney LB; Nurko S; Rosen R
J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
[TBL] [Abstract][Full Text] [Related]
8. The role of impedance monitoring in patients with extraesophageal symptoms.
Kavitt RT; Yuksel ES; Slaughter JC; Garrett CG; Hagaman D; Higginbotham T; Vaezi MF
Laryngoscope; 2013 Oct; 123(10):2463-8. PubMed ID: 23857711
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis.
Familiari P; Greco S; Gigante G; Calì A; Boškoski I; Onder G; Perri V; Costamagna G
Dig Endosc; 2016 Jan; 28(1):33-41. PubMed ID: 26173511
[TBL] [Abstract][Full Text] [Related]
10. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
Vailati C; Mazzoleni G; Testoni PA; Passaretti S
J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
[TBL] [Abstract][Full Text] [Related]
11. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
13. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease.
Patti MG; Diener U; Tamburini A; Molena D; Way LW
Dig Dis Sci; 2001 Mar; 46(3):597-602. PubMed ID: 11318538
[TBL] [Abstract][Full Text] [Related]
14. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
[TBL] [Abstract][Full Text] [Related]
15. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
Vardar R; Keskin M
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
[TBL] [Abstract][Full Text] [Related]
16. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
17. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
Shetler KP; Bikhtii S; Triadafilopoulos G
Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475749
[TBL] [Abstract][Full Text] [Related]
18. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease.
Visaggi P; Del Corso G; Gyawali CP; Ghisa M; Baiano Svizzero F; Stefani Donati D; Venturini A; Savarino V; Penagini R; Zeki S; Bellini M; Savarino EV; de Bortoli N
Am J Gastroenterol; 2023 May; 118(5):794-801. PubMed ID: 36633477
[TBL] [Abstract][Full Text] [Related]
20. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
